566 related articles for article (PubMed ID: 31227439)
1. Deep latency: A new insight into a functional HIV cure.
Elsheikh MM; Tang Y; Li D; Jiang G
EBioMedicine; 2019 Jul; 45():624-629. PubMed ID: 31227439
[TBL] [Abstract][Full Text] [Related]
2. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
3. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
4. Implications of HIV-1 Nef for "Shock and Kill" Strategies to Eliminate Latent Viral Reservoirs.
Kuang XT; Brockman MA
Viruses; 2018 Nov; 10(12):. PubMed ID: 30513570
[TBL] [Abstract][Full Text] [Related]
5. Selective BCL-X
Ren Y; Huang SH; Macedo AB; Ward AR; Alberto WDC; Klevorn T; Leyre L; Copertino DC; Mota TM; Chan D; Truong R; Rohwetter T; Zumbo P; Dündar F; Betel D; Kovacs C; Benko E; Bosque A; Jones RB
J Virol; 2021 Jul; 95(15):e0242520. PubMed ID: 33980597
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies.
Khanal S; Schank M; El Gazzar M; Moorman JP; Yao ZQ
Cells; 2021 Feb; 10(2):. PubMed ID: 33672138
[TBL] [Abstract][Full Text] [Related]
7. The Splice of Life: Does RNA Processing Have a Role in HIV-1 Persistence?
Pasternak AO; Berkhout B
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578332
[TBL] [Abstract][Full Text] [Related]
8. On the way to find a cure: Purging latent HIV-1 reservoirs.
Schwartz C; Bouchat S; Marban C; Gautier V; Van Lint C; Rohr O; Le Douce V
Biochem Pharmacol; 2017 Dec; 146():10-22. PubMed ID: 28687465
[TBL] [Abstract][Full Text] [Related]
9. Block and Lock HIV Cure Strategies to Control the Latent Reservoir.
Ahlenstiel CL; Symonds G; Kent SJ; Kelleher AD
Front Cell Infect Microbiol; 2020; 10():424. PubMed ID: 32923412
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
J Virol; 2018 May; 92(9):. PubMed ID: 29491162
[TBL] [Abstract][Full Text] [Related]
11. Reduce and Control: A Combinatorial Strategy for Achieving Sustained HIV Remissions in the Absence of Antiretroviral Therapy.
Schwarzer R; Gramatica A; Greene WC
Viruses; 2020 Feb; 12(2):. PubMed ID: 32046251
[TBL] [Abstract][Full Text] [Related]
12. Assays to Measure Latency, Reservoirs, and Reactivation.
Siliciano JD; Siliciano RF
Curr Top Microbiol Immunol; 2018; 417():23-41. PubMed ID: 29071475
[TBL] [Abstract][Full Text] [Related]
13. Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure.
Duggan NN; Dragic T; Chanda SK; Pache L
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140676
[TBL] [Abstract][Full Text] [Related]
14. Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs.
Sadowski I; Hashemi FB
Cell Mol Life Sci; 2019 Sep; 76(18):3583-3600. PubMed ID: 31129856
[TBL] [Abstract][Full Text] [Related]
15. New latency-promoting agents for a block-and-lock functional cure strategy.
Pellaers E; Denis A; Debyser Z
Curr Opin HIV AIDS; 2024 May; 19(3):95-101. PubMed ID: 38457209
[TBL] [Abstract][Full Text] [Related]
16. Experimental Systems for Measuring HIV Latency and Reactivation.
Fujinaga K; Cary DC
Viruses; 2020 Nov; 12(11):. PubMed ID: 33182414
[TBL] [Abstract][Full Text] [Related]
17. Fused in sarcoma silences HIV gene transcription and maintains viral latency through suppressing AFF4 gene activation.
Krasnopolsky S; Marom L; Victor RA; Kuzmina A; Schwartz JC; Fujinaga K; Taube R
Retrovirology; 2019 Jun; 16(1):16. PubMed ID: 31238957
[TBL] [Abstract][Full Text] [Related]
18. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
[TBL] [Abstract][Full Text] [Related]
19. A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG).
Huang H; Kong W; Jean M; Fiches G; Zhou D; Hayashi T; Que J; Santoso N; Zhu J
Nucleic Acids Res; 2019 Aug; 47(14):7333-7347. PubMed ID: 31165872
[TBL] [Abstract][Full Text] [Related]
20. The Current Status of Latency Reversing Agents for HIV-1 Remission.
Rodari A; Darcis G; Van Lint CM
Annu Rev Virol; 2021 Sep; 8(1):491-514. PubMed ID: 34586875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
